COVID-19 Therapy: the Role of Antirheumatic Drugs
Currently, the close attention of the medical and international community is still riveted on the novel coronavirus infection, which caused the pandemic in 2020. Understanding the underlying mechanisms of coronavirus disease-2019 (COVID-19) made it possible to move from the empirical selection of th...
Saved in:
| Main Authors: | M. A. Litvinova, N. V. Muravyeva, B. S. Belov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2021-10-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/842 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BARICITINIB: NEW PHARMACOTHERAPY OPTIONS FOR RHEUMATOID ARTHRITIS AND OTHER IMMUNE-MEDIATED INFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2020-06-01) -
Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
by: Daniel Muñoz-Barba, et al.
Published: (2025-07-01) -
Case report: Effectiveness of Janus kinase inhibitors in the management of isolated noninfectious uveitis: a case series
by: Nina Vidic Krhlikar, et al.
Published: (2025-03-01) -
Two pemphigoid cases with mucous membrane involvement successfully treated with baricitinib
by: Tamás Malkovics, et al.
Published: (2024-12-01) -
Weight gain secondary to the use of oral Janus kinase inhibitors: A systematic review and meta-analysis
by: Grace Xiong, BHSc, et al.
Published: (2025-04-01)